PharmaLectures.com

Courses › Regulatory affairs by region › European Union: Swissmedic, and where Switzerland quietly differs from the EU

European Union: Swissmedic, and where Switzerland quietly differs from the EU

Your team files for Swissmedic right the first time, not for the European agency.

  • 5 audio modulesthree lengths each
  • 50 min to 4 h 10 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why this training matters

Your team sends Swissmedic a dossier built to European Medicines Agency rules. It comes back, and Module 1 of the Common Technical Document is rewritten in a rush while the launch date slips. Your Swiss partner asks on the next call whether the deadline still holds.

What changes after this course

Before anyone drafts, your team checks where Swiss law departs from Directive 2001/83/EC. At the inspection, they answer in the room. You hold a certificate per learner and a per-person training record to put straight into the audit file.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team stops assuming that European Medicines Agency practice holds in Bern. When a question about Directive 2001/83/EC comes up in a project meeting, someone answers on the spot whether the Swiss Therapeutic Products Act follows the same standard or needs a local step. Submissions get drafted for Swissmedic from the first page.

At the inspection, your quality assurance specialist opens the site master file and already knows what Swissmedic will ask next. Good Manufacturing Practice records, the import licence and the batch release documents are in order, so a finding does not turn into a held batch.

Pharmacovigilance officers stop comparing European Good Pharmacovigilance Practices with Swiss rules each time a reaction comes in. They send the report to the right authority on the first try, and the risk management plan reaches Swissmedic in a form that does not trigger another round of questions.

Business development colleagues walk into the board meeting with a straight answer on what Article 13 of the Therapeutic Products Act can do for a product already approved in Europe, and what still has to be prepared locally before Swissmedic decides.

Who needs this training

  • Regulatory Affairs Manager

    You are about to finalise a Swiss submission from a European dossier, and you need to know which parts of Module 1 and the Common Technical Document must change before it goes to Swissmedic.

  • Quality Assurance Specialist

    A Swissmedic inspector asks for your site master file and your Swiss batch release procedure, and you want the answer ready before the inspection day, not during it.

  • Business Development Lead

    You present a Swiss market entry plan to the board and need to say what Article 13 of the Therapeutic Products Act does for a product approved in Europe, and what it does not.

  • Pharmacovigilance Officer

    A new adverse drug reaction arrives and you must decide quickly whether it goes to Swissmedic, the European database, or both, without checking three documents first.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Point to the places where the Swiss Therapeutic Products Act and Directive 2001/83/EC ask for different things.
  2. Rework Module 1 of a Common Technical Document so it fits a Swissmedic procedure.
  3. Answer a Swissmedic inspector's question on Good Manufacturing Practice and Swiss batch release on the spot.
  4. Decide whether an adverse drug reaction goes to Swissmedic, the European database, or both.
  5. Check whether a product approved in Europe can use Article 13 of the Therapeutic Products Act.
  6. Adjust a European risk management plan so it meets Swiss post-market surveillance expectations.

What the company gets

  • Dossiers stop coming back from Swissmedic because of European formatting, so launch dates hold and your Swiss partner stops asking about delays.
  • Your quality team arrives at a Swiss inspection with the site master file ready and the batch release records to hand.
  • Safety reports reach the right authority on time, which keeps your pharmacovigilance file clean at the next review.
  • Your business development lead can tell the board what Article 13 of the Therapeutic Products Act may shorten and what still needs local work.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 5 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing50 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 05 min25 min a module, for regulatory, quality and business-development staff
Expanded4 h 10 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing50 min
Regulatory affairsStandard2 h 05 min
Quality assurance and Qualified PersonStandard2 h 05 min

Course outline: 5 modules

5 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Spot where Swiss law departs from Directive 2001/83/EC

    • Why a European Union definition cannot be carried into a Swiss submission word for word.
    • How to tell in the meeting whether a question needs a Swiss legal review or only a note to file.
    • The points where the Swiss Therapeutic Products Act asks for more than Directive 2001/83/EC does.
  2. 2Predict how Swissmedic applies rules differently from European authorities

    • Why a European approval does not buy a quick yes from Swissmedic.
    • What to do when Swissmedic asks for something the European agency never did.
    • The inspection powers Swissmedic holds under the Therapeutic Products Act, including at foreign sites.
  3. 3Build a Common Technical Document that fits Swissmedic procedures

    • What to change in Module 1 before your Common Technical Document goes to Bern.
    • When Article 13 lets Swissmedic take a foreign assessment into account, and when not to count on it.
    • The sections where Swissmedic wants local content, so you stop rebuilding the dossier after a refusal.
  4. 4Pass Swissmedic Good Manufacturing Practice inspections without batch delays

    • How to bring your site master file into the shape a Swissmedic inspector expects before they arrive.
    • What to say when the inspector asks for your Swiss batch release procedure.
    • The import licence and batch release records that keep a shipment moving into Switzerland.
  5. 5Report adverse reactions the way Swiss post-market surveillance expects

    • When a reaction must be reported to Swissmedic and when a European database report is not enough.
    • How to adapt your European risk management plan so Swissmedic accepts it without another round.
    • The safety updates Swiss post-market surveillance expects, so your file is complete the first time.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

5 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 50 min in the briefing length and 4 h 10 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 45 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team